Leptin hormone: Phase II

AMGN reported that leptin failed to produce statistically significant weight loss versus placebo at three months in two Phase II trials. The company said it identified a patient subset that did show statistically significant weight loss, and it is developing a protocol for an additional Phase II trial in this population (see BioCentury Extra, Oct. 29). ...